Review: could Lamictal cause Gait Disturbance?


Gait disturbance is found among people who take Lamictal, especially for people who are female, 50-59 old , have been taking the drug for < 1 month, also take medication Keppra, and have Bipolar disorder . We study 38,208 people who have side effects while taking Lamictal from FDA and social media. Among them, 472 have Gait disturbance. Find out below who they are, when they have Gait disturbance and more.

You are not alone

Join a support group for people who take Lamictal and have Gait disturbance >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Lamictal has active ingredients of lamotrigine. It is often used in bipolar disorder. (latest outcomes from Lamictal 40,259 users)

Gait Disturbance

Gait disturbance has been reported by people with abasia, urinary tract infection, weakness, fatigue, fall (latest reports from 46,108 Gait disturbance patients).

On Jul, 27, 2016

38,208 people reported to have side effects when taking Lamictal.
Among them, 472 people (1.24%) have Gait Disturbance

Number of reports submitted per year:

Could Lamictal cause Gait disturbance?

Time on Lamictal when people have Gait Disturbance *:

  • < 1 month: 50.88 %
  • 1 - 6 months: 24.56 %
  • 6 - 12 months: 5.26 %
  • 1 - 2 years: 10.53 %
  • 2 - 5 years: 5.26 %
  • 5 - 10 years: 3.51 %
  • 10+ years: 0.0 %

Gender of people who have Gait Disturbance when taking Lamictal *:

  • female: 67.88 %
  • male: 32.12 %

Age of people who have Gait Disturbance when taking Lamictal *:

  • 0-1: 0.0 %
  • 2-9: 2.33 %
  • 10-19: 6.98 %
  • 20-29: 9.3 %
  • 30-39: 13.18 %
  • 40-49: 23.77 %
  • 50-59: 24.81 %
  • 60+: 19.64 %

Top conditions involved for these people *:

  • Bipolar Disorder (97 people)
  • Epilepsy (79 people)
  • Convulsion (52 people)
  • Depression (35 people)
  • Multiple Sclerosis (29 people)

Top co-used drugs for these people *:

  • Keppra (63 people)
  • Cymbalta (41 people)
  • Seroquel (40 people)
  • Klonopin (36 people)
  • Tegretol (35 people)

* Approximation only. Some reports may have incomplete information.

** Reports from social media are used.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you have Gait disturbance when taking Lamictal?

Browse all side effects of Lamictal

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Gait disturbance

Gait disturbance

Could your condition cause Gait disturbance

Gait disturbance

Can you answer these questions?

More questions for: Lamictal, Gait disturbance

You may be interested in these reviews

More reviews for: Lamictal, Gait disturbance

NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.